Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History

COPD: Pathogenesis and Clinical Features

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Defining an Ageing-Related Pathology, Disease or Syndrome: International Consensus Statement.

medRxiv : the preprint server for health sciences·2024

Same author

A simple and effective evidence-based approach to asthma management: ICS-formoterol reliever therapy.

The British journal of general practice : the journal of the Royal College of General Practitioners·2024

Same author

DEL-1, as an anti-neutrophil transepithelial migration molecule, inhibits airway neutrophilic inflammation in asthma.

Allergy·2023

Same author

Rational use of inhaled corticosteroids for the treatment of COPD.

NPJ primary care respiratory medicine·2023

Same author

Autophagy in asthma and chronic obstructive pulmonary disease.

Clinical science (London, England : 1979)·2022

Same author

Hepcidin Is Essential for Alveolar Macrophage Function and Is Disrupted by Smoke in a Murine Chronic Obstructive Pulmonary Disease Model.

Journal of immunology (Baltimore, Md. : 1950)·2020

Search research articles

Related Experiment Video

Updated: Sep 21, 2025

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

Oxidative Stress in Chronic Obstructive Pulmonary Disease.

Peter J Barnes¹

¹National Heart and Lung Institute, Imperial College London, London SW5 9LH, UK.

Antioxidants (Basel, Switzerland)

|May 28, 2022

Summary

Oxidative stress significantly harms COPD lungs, driving inflammation and disease progression. New antioxidants targeting mitochondria, NOX, and Nrf2 pathways show promise for treating this complex respiratory disease.

Keywords:

8-isoprostane Nrf2 antioxidants cellular senescence inflammation

More Related Videos

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury

Published on: March 21, 2021

Analysis of Oxidative Stress in Zebrafish Embryos

Analysis of Oxidative Stress in Zebrafish Embryos

Published on: July 7, 2014

Related Experiment Videos

Last Updated: Sep 21, 2025

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury

Published on: March 21, 2021

Analysis of Oxidative Stress in Zebrafish Embryos

Analysis of Oxidative Stress in Zebrafish Embryos

Published on: July 7, 2014

Area of Science:

Pulmonary Medicine
Oxidative Stress Research
Pharmacology

Background:

Chronic Obstructive Pulmonary Disease (COPD) is characterized by increased oxidative stress in the lungs, evidenced by elevated biomarkers like 8-isoprostane.
Both external factors (pollution, smoking) and internal sources (inflammatory cells) contribute to lung oxidative stress in COPD.
Reduced antioxidant defenses and poor dietary intake can exacerbate oxidative stress in COPD patients.

Purpose of the Study:

To elucidate the role of oxidative stress in COPD pathogenesis and progression.
To evaluate the potential of antioxidants as disease-modifying treatments for COPD.
To identify limitations of current antioxidant therapies and explore novel therapeutic strategies.

Main Methods:

Assessment of oxidative stress markers in COPD patients' breath (e.g., 8-isoprostane, ethane, hydrogen peroxide).
Review of mechanisms by which oxidative stress drives COPD pathology, including inflammation and cellular dysfunction.
Analysis of the efficacy and limitations of existing antioxidant treatments like N-acetylcysteine.

Main Results:

Oxidative stress is a key driver of COPD, inducing chronic inflammation, cellular senescence, impaired autophagy, and reduced DNA repair.
Oxidative stress contributes to disease progression, exacerbations, and systemic comorbidities.
Thiol-based antioxidants (e.g., N-acetylcysteine) have shown limited efficacy due to inactivation by lung oxidative stress.

Conclusions:

Oxidative stress is central to COPD pathology and progression, necessitating effective therapeutic interventions.
Novel antioxidant strategies, including mitochondria-targeted agents, NOX inhibitors, and Nrf2 activators, are under development.
Developing safer and more effective antioxidants is crucial for managing COPD and improving patient outcomes.